Successful treatment of refractory TAFRO syndrome with elevated vascular endothelial growth factor using thyroxine supplements

Although the clinical significance of hypothyroidism in TAFRO syndrome is unknown, vascular endothelial growth factor (VEGF) levels decreased with improvements in the condition of our refractory TAFRO cases after thyroxine supplement therapy. Our results indicate that elevated VEGF levels are a pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Oka, Satoko, Ono, Kazuo, Nohgawa, Masaharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889265/
https://www.ncbi.nlm.nih.gov/pubmed/29636932
http://dx.doi.org/10.1002/ccr3.1430
_version_ 1783312673628225536
author Oka, Satoko
Ono, Kazuo
Nohgawa, Masaharu
author_facet Oka, Satoko
Ono, Kazuo
Nohgawa, Masaharu
author_sort Oka, Satoko
collection PubMed
description Although the clinical significance of hypothyroidism in TAFRO syndrome is unknown, vascular endothelial growth factor (VEGF) levels decreased with improvements in the condition of our refractory TAFRO cases after thyroxine supplement therapy. Our results indicate that elevated VEGF levels are a potential factor in the pathogenesis and anasarca of TAFRO syndrome with hypothyroidism.
format Online
Article
Text
id pubmed-5889265
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-58892652018-04-10 Successful treatment of refractory TAFRO syndrome with elevated vascular endothelial growth factor using thyroxine supplements Oka, Satoko Ono, Kazuo Nohgawa, Masaharu Clin Case Rep Case Reports Although the clinical significance of hypothyroidism in TAFRO syndrome is unknown, vascular endothelial growth factor (VEGF) levels decreased with improvements in the condition of our refractory TAFRO cases after thyroxine supplement therapy. Our results indicate that elevated VEGF levels are a potential factor in the pathogenesis and anasarca of TAFRO syndrome with hypothyroidism. John Wiley and Sons Inc. 2018-02-21 /pmc/articles/PMC5889265/ /pubmed/29636932 http://dx.doi.org/10.1002/ccr3.1430 Text en © 2018 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Oka, Satoko
Ono, Kazuo
Nohgawa, Masaharu
Successful treatment of refractory TAFRO syndrome with elevated vascular endothelial growth factor using thyroxine supplements
title Successful treatment of refractory TAFRO syndrome with elevated vascular endothelial growth factor using thyroxine supplements
title_full Successful treatment of refractory TAFRO syndrome with elevated vascular endothelial growth factor using thyroxine supplements
title_fullStr Successful treatment of refractory TAFRO syndrome with elevated vascular endothelial growth factor using thyroxine supplements
title_full_unstemmed Successful treatment of refractory TAFRO syndrome with elevated vascular endothelial growth factor using thyroxine supplements
title_short Successful treatment of refractory TAFRO syndrome with elevated vascular endothelial growth factor using thyroxine supplements
title_sort successful treatment of refractory tafro syndrome with elevated vascular endothelial growth factor using thyroxine supplements
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889265/
https://www.ncbi.nlm.nih.gov/pubmed/29636932
http://dx.doi.org/10.1002/ccr3.1430
work_keys_str_mv AT okasatoko successfultreatmentofrefractorytafrosyndromewithelevatedvascularendothelialgrowthfactorusingthyroxinesupplements
AT onokazuo successfultreatmentofrefractorytafrosyndromewithelevatedvascularendothelialgrowthfactorusingthyroxinesupplements
AT nohgawamasaharu successfultreatmentofrefractorytafrosyndromewithelevatedvascularendothelialgrowthfactorusingthyroxinesupplements

Ejemplares similares